Napoli Bern Ripka, LLP Blog

Bayer Recalls Popular Drug Used In Heart Surgery

Bayer Pharmaceutical, the large drug manufacturer, has announced that it has taken its remaining stock of Trasylol out of hospitals. This anti-bleeding medication has been linked to causing kidney damage and death in over 22,000 cases. The reason that Bayer recalled the drug was in response from studies that show Trasylol nearly doubled the death rate in comparison to cheaper alternative medications that were already established in the market. These studies that proved Trasylol, also called aprotinin, is more dangerous when used in heart surgeries were given to Bayer nearly two years before it was taken off the market. Bayer even did their own study, in which the finding also discovered the fatal side effects of the drug.

Now that Trasylol has been taken off the market it is time to recoup all that has been lost. This is another example of large drug company whose questionable motives have cost numerous lives and much grief. The firm of Napoli Bern Ripka, LLP represents victims of such second-rate care and negligence. We have the experienced legal team that has successfully represented thousands of clients injured by medical drugs such as Fen-phen, Baycol, and Rezulin, and are here to help you with any Trasylol questions you may have.